USPTO trademark

Progenics Pharmaceuticals, Inc design mark 7278207

RegisteredUSPTOFigurative markClass 9Class 42

"Design mark 7278207" is a figurative mark owned by Progenics Pharmaceuticals, Inc., filed at the USPTO on December 29, 2022. It is registered and covers classes 9 and 42.

View Progenics Pharmaceuticals, Inc. portfolio Get this data via the API

Data current as of January 16, 2024Official USPTO record

As filed with the USPTO

Status: Registered; Since January 16, 2024
Filed: December 29, 2022
Registered: January 16, 2024
Expires: Not recorded
Application no.: 97735993
Registration no.: 7278207
Office: USPTO; United States Patent and Trademark Office
Mark type: Figurative mark; 2 classes

Ownership

Who owns Progenics Pharmaceuticals, Inc design mark 7278207

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Progenics Pharmaceuticals, Inc.

Bedford, United States

61 trademarks in the portfolioView company

Representative

Douglas R. Wolf

Wolf, Greenfield & Sacks, P.C.

Goods and services

What the mark covers

The products and services Progenics Pharmaceuticals, Inc design mark 7278207 is filed for, grouped by Nice class.

09Class 9 · Computers and Scientific Devices
downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer
42Class 42 · Computer and Scientific Services
providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer

History

What has happened so far

Steps recorded by the USPTO, newest first.

January 22, 2024Notice of registration confirmation emailed
January 16, 2024Notice of registration confirmation emailed
January 16, 2024Registered-principal register
October 31, 2023Official gazette publication confirmation e-mailed
October 31, 2023Published for opposition
October 11, 2023Notification of notice of publication e-mailed
September 26, 2023Approved for pub - principal register
September 26, 2023Assigned to examiner
January 25, 2023Notice of design search code e-mailed
January 24, 2023New application office supplied data entered

1 earlier step on the official record.

FAQ

About Progenics Pharmaceuticals, Inc design mark 7278207

Who owns the trademark "Design mark 7278207"?

The USPTO trademark "Design mark 7278207" (application 97735993) is owned by Progenics Pharmaceuticals, Inc.

What is the status of "Design mark 7278207"?

Its status at the USPTO is: registered.

When was "Design mark 7278207" registered?

It was registered on January 16, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Progenics Pharmaceuticals, Inc design mark 7278207 and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2b3e-6ac8-7178-9582-af239a5913b4
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2b3e-6ac8-7178-9582-af239a5913b4",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97735993",
  "filing_date": "2022-12-29",
  "nice_classes": [
    9,
    42
  ],
  "owners": [
    {
      "name": "Progenics Pharmaceuticals, Inc.",
      "entity_id": "ent_019f285f-865e-71ce-91bd-fb51977fd38d"
    }
  ]
}